The conjugated antimetabolite 5-FdU-ECyd and its cellular and molecular effects on platinum-sensitive vs. -resistant ovarian cancer cells in vitro

BACKGROUND: Resistance to platinum-based chemotherapy is a clinical challenge in the treatment of ovarian cancer (OC) and limits survival. Therefore, innovative drugs against platinum-resistance are urgently needed. Our therapeutic concept is based on the conjugation of two chemotherapeutic compound...

Descripción completa

Detalles Bibliográficos
Autores principales: Schott, Sarah, Wimberger, Pauline, Klink, Barbara, Grützmann, Konrad, Puppe, Julian, Wauer, Ulrike Sophie, Klotz, Daniel Martin, Schröck, Evelin, Kuhlmann, Jan Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652753/
https://www.ncbi.nlm.nih.gov/pubmed/29100359
http://dx.doi.org/10.18632/oncotarget.20260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652753/
https://www.ncbi.nlm.nih.gov/pubmed/29100359
http://dx.doi.org/10.18632/oncotarget.20260

Ejemplares similares